全文获取类型
收费全文 | 10542篇 |
免费 | 472篇 |
国内免费 | 56篇 |
专业分类
耳鼻咽喉 | 57篇 |
儿科学 | 223篇 |
妇产科学 | 78篇 |
基础医学 | 1257篇 |
口腔科学 | 145篇 |
临床医学 | 661篇 |
内科学 | 2715篇 |
皮肤病学 | 250篇 |
神经病学 | 745篇 |
特种医学 | 557篇 |
外科学 | 1798篇 |
综合类 | 31篇 |
预防医学 | 388篇 |
眼科学 | 189篇 |
药学 | 782篇 |
中国医学 | 41篇 |
肿瘤学 | 1153篇 |
出版年
2023年 | 41篇 |
2021年 | 163篇 |
2020年 | 114篇 |
2019年 | 136篇 |
2018年 | 161篇 |
2017年 | 149篇 |
2016年 | 180篇 |
2015年 | 179篇 |
2014年 | 244篇 |
2013年 | 322篇 |
2012年 | 515篇 |
2011年 | 568篇 |
2010年 | 304篇 |
2009年 | 280篇 |
2008年 | 475篇 |
2007年 | 544篇 |
2006年 | 540篇 |
2005年 | 581篇 |
2004年 | 594篇 |
2003年 | 605篇 |
2002年 | 563篇 |
2001年 | 353篇 |
2000年 | 378篇 |
1999年 | 363篇 |
1998年 | 131篇 |
1997年 | 120篇 |
1996年 | 105篇 |
1995年 | 87篇 |
1994年 | 64篇 |
1993年 | 69篇 |
1992年 | 172篇 |
1991年 | 172篇 |
1990年 | 181篇 |
1989年 | 164篇 |
1988年 | 162篇 |
1987年 | 128篇 |
1986年 | 130篇 |
1985年 | 127篇 |
1984年 | 85篇 |
1983年 | 97篇 |
1982年 | 49篇 |
1981年 | 45篇 |
1980年 | 45篇 |
1979年 | 75篇 |
1978年 | 62篇 |
1977年 | 36篇 |
1975年 | 51篇 |
1974年 | 42篇 |
1970年 | 44篇 |
1967年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
1.
Mamiko Onuki Koji Matsumoto Takashi Iwata Kasumi Yamamoto Yoichi Aoki Shoji Maenohara Naotake Tsuda Shoji Kamiura Kazuhiro Takehara Koji Horie Nobutaka Tasaka Hideaki Yahata Yuji Takei Yoichi Aoki Hisamori Kato Takeshi Motohara Keiichiro Nakamura Mitsuya Ishikawa Tatsuya Kato Hiroyuki Yoshida Noriomi Matsumura Hidekatsu Nakai Shogo Shigeta Fumiaki Takahashi Kiichiro Noda Nobuo Yaegashi Hiroyuki Yoshikawa 《Cancer science》2020,111(7):2546-2557
To obtain baseline data for cervical cancer prevention in Japan, we analyzed human papillomavirus (HPV) data from 5045 Japanese women aged less than 40 years and diagnosed with cervical abnormalities at 21 hospitals during 2012‐2017. These included cervical intraepithelial neoplasia grade 1 (CIN1, n = 573), CIN2‐3 (n = 3219), adenocarcinoma in situ (AIS, n = 123), and invasive cervical cancer (ICC, n = 1130). The Roche Linear Array was used for HPV genotyping. The HPV type‐specific relative contributions (RCs) were estimated by adding multiple infections to single types in accordance with proportional weighting attributions. Based on the comparison of type‐specific RCs between CIN1 and CIN2‐3/AIS/ICC (CIN2+), RC ratios were calculated to estimate type‐specific risks for progression to CIN2+. Human papillomavirus DNA was detected in 85.5% of CIN1, 95.7% of CIN2‐3/AIS, and 91.2% of ICC. Multiple infections decreased with disease severity: 42.9% in CIN1, 40.4% in CIN2‐3/AIS, and 23.7% in ICC (P < .0001). The relative risk for progression to CIN2+ was highest for HPV16 (RC ratio 3.78, 95% confidence interval [CI] 3.01‐4.98), followed by HPV31 (2.51, 1.54‐5.24), HPV18 (2.43, 1.59‐4.32), HPV35 (1.56, 0.43‐8.36), HPV33 (1.01, 0.49‐3.31), HPV52 (0.99, 0.76‐1.33), and HPV58 (0.97, 0.75‐1.32). The relative risk of disease progression was 1.87 (95% CI, 1.71‐2.05) for HPV16/18/31/33/35/45/52/58, but only 0.17 (95% CI, 0.14‐0.22) for HPV39/51/56/59/66/68. Human papillomavirus 16/18/31/33/45/52/58/6/11 included in a 9‐valent vaccine contributed to 89.7% (95% CI, 88.7‐90.7) of CIN2‐3/AIS and 93.8% (95% CI, 92.4‐95.3) of ICC. In conclusion, our data support the Japanese guidelines that recommend discriminating HPV16/18/31/33/35/45/52/58 genotypes for CIN management. The 9‐valent vaccine is estimated to provide over 90% protection against ICC in young Japanese women. 相似文献
2.
3.
4.
5.
Tetsuya Katsumori Tatsuya Yoshikawa Yasuteru Sasakura Toshinori Yasumura Mitsuhiro Hisano 《Journal of vascular and interventional radiology : JVIR》2021,32(3):332-338
PurposeTo investigate differences in outcomes of uterine artery embolization (UAE) for leiomyoma when performed during different phases of the menstrual cycle.Materials and MethodsIn this single-institution retrospective analysis, 111 premenopausal patients (median [range] age, 44 [33–52] years) undergoing UAE for symptomatic leiomyoma between June 2014 and February 2020 were included. Twenty-one patients underwent UAE in the menstrual phase (the early follicular phase), 27 in the late follicular phase, and 63 in the luteal phase. Baseline characteristics and technical and peri-procedural outcomes were compared among groups. Leiomyoma infarction on contrast-enhanced magnetic resonance imaging 1 week after UAE and 4-month outcomes, including changes in the Uterine Fibroid Symptom and Quality of Life questionnaire scores, the volume reduction rates of the uterus and largest leiomyoma, follicle stimulating hormone values, adverse events, and amenorrhea, were compared among groups.ResultsA 4-month follow-up was completed for all patients. No significant differences were observed among groups in baseline characteristics or technical and peri-procedural outcomes. There were no significant differences in the multivariate-adjusted 1-week infarction rates of all leiomyoma volumes (P = .161) or multivariate-adjusted 4-month outcomes, including changes in the Uterine Fibroid Symptom and Quality of Life questionnaire symptoms and total scores (P = .864 and P = .798, respectively), the volume reduction rates of the uterus and the largest leiomyoma (P = .865 and P = .965, respectively), and follicle stimulating hormone values (P = .186) among the groups. No significant differences were noted in the 4-month adverse events (P = .260) or amenorrhea (P = .793) among the groups.ConclusionsThe present study demonstrated no significant differences in the outcomes of UAE for leiomyoma when performed during different phases of the menstrual cycle. 相似文献
6.
Manabu Fujimoto Jun Asai Yoshihide Asano Takayuki Ishii Yohei Iwata Tamihiro Kawakami Masanari Kodera Masatoshi Abe Masahiro Amano Ryuta Ikegami Taiki Isei Zenzo Isogai Takaaki Ito Yuji Inoue Ryokichi Irisawa Masaki Ohtsuka Yoichi Omoto Hiroshi Kato Takafumi Kadono Sakae Kaneko Hiroyuki Kanoh Masakazu Kawaguchi Ryuichi Kukino Takeshi Kono Monji Koga Keisuke Sakai Eiichi Sakurai Yasuko Sarayama Yoichi Shintani Miki Tanioka Hideaki Tanizaki Jun Tsujita Naotaka Doi Takeshi Nakanishi Akira Hashimoto Minoru Hasegawa Masahiro Hayashi Kuninori Hirosaki Hideki Fujita Hiroshi Fujiwara Takeo Maekawa Koma Matsuo Naoki Madokoro Sei-Ichiro Motegi Hiroshi Yatsushiro Osamu Yamasaki Yuichiro Yoshino Andres James LE Pavoux Takao Tachibana Hironobu Ihn Japanese Dermatological Association Guidelines 《The Journal of dermatology》2020,47(10):1071-1109
The Japanese Dermatological Association prepared guidelines focused on the treatment of skin ulcers associated with connective tissue disease/vasculitis practical in clinical settings of dermatological care. Skin ulcers associated with connective tissue diseases or vasculitis occur on the background of a wide variety of diseases including, typically, systemic sclerosis but also systemic lupus erythematosus (SLE), dermatomyositis, rheumatoid arthritis (RA), various vasculitides and antiphospholipid antibody syndrome (APS). Therefore, in preparing the present guidelines, we considered diagnostic/therapeutic approaches appropriate for each of these disorders to be necessary and developed algorithms and clinical questions for systemic sclerosis, SLE, dermatomyositis, RA, vasculitis and APS. 相似文献
7.
Masatake Kobayashi Kazunori Nanri Takeshi Taguchi Tomoko Ishiko Masaharu Yoshida Noriko Yoshikawa Kentaro Sugisaki Nobuyuki Tanaka 《Journal of clinical apheresis》2015,30(1):43-45
Neuromyelitis optica (NMO) is a severe inflammatory demyelinating disease with exacerbations involving recurrent or bilateral optic neuritis and longitudinally extensive transverse myelitis. Pulse steroid therapy is recommended as the initial, acute‐phase treatment for NMO. If ineffective, treatment with plasma exchange (PE) should commence. However, no evidence exists to support the effectiveness of PE long after the acute phase. Immunoadsorption therapy (IA) eliminates pathogenic antibodies while sparing other plasma proteins. With IA, side effects of PE resulting from protein substitution can be avoided. However, whether IA is effective for NMO remains unclear. We describe a patient with anti‐aquaporin‐4‐positive myelitis who responded to IA using a tryptophan polyvinyl alcohol gel column that was begun 52 days after disease onset following the acute phase. Even long after the acute phase when symptoms appear to be stable, IA may be effective and should not be excluded as a treatment choice. J. Clin. Apheresis 30:43–45, 2015. © 2014 Wiley Periodicals, Inc. 相似文献
8.
Seisuke Ata Shogo Yamane Yoshihiro Hayashi Susumu Kawauchi Junji Mizukado Takeo Yamada Kenji Hata 《Macromolecular chemistry and physics.》2019,220(22)
This paper demonstrates that carbon nanotubes (CNTs) can be used as an effective filler for inhibiting the hydrolysis of polyurethane (PU) under acidic and basic conditions. Although it has been reported that CNTs can quench the radicals on its surface, for the first time, it is confirmed that CNTs undergo reactions that have an inhibiting effect on ion‐mediated hydrolysis. Attenuated total reflectance–infrared spectroscopy measurements on PU and PU–CNT samples reveal that CNTs inhibit the hydrolysis of PU in both acid and alkaline environments. Via quantum chemical calculations, it is shown that CNTs can trap H+ ions and OH? ions on their surface. It is also shown that CNTs can trap multiple ions, even though electrical repulsion is to be expected. The results reveal that CNTs can also function as a hydrolysis inhibitor in addition to their known functions as an antioxidant. 相似文献
9.
10.